Nakanishi H, Chrusciel R A, Shen R, Bertenshaw S, Johnson M E, Rydel T J, Tulinsky A, Kahn M
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago 60680.
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1705-9. doi: 10.1073/pnas.89.5.1705.
Recent work has suggested that the thrombin-bound conformation of fibrinopeptide A exhibits a strand-turn-strand motif, with a beta-turn centered at residues Glu-11 and Gly-12. Our molecular modeling analysis indicates that the published fibrinopeptide conformation cannot bind reasonably to thrombin but that reorientation of two residues by alignment with bovine pancreatic trypsin inhibitor provides a good fit within the deep thrombin cleft and satisfies all of the experimental nuclear Overhauser effect data. Based on this analysis, we have successfully designed and synthesized hybrid peptide mimetic substrates and inhibitors that mimic the proposed beta-turn structure. The results indicate that the turn conformation is an important aspect of thrombin specificity and that our turn mimetic design successfully mimics the thrombin-bound conformation of fibrinopeptide.
最近的研究表明,与凝血酶结合的纤维蛋白肽A的构象呈现出链-转角-链基序,其β-转角以Glu-11和Gly-12残基为中心。我们的分子模拟分析表明,已发表的纤维蛋白肽构象无法合理地与凝血酶结合,但通过与牛胰蛋白酶抑制剂比对使两个残基重新定向后,能很好地契合凝血酶的深裂隙,并符合所有实验性核Overhauser效应数据。基于此分析,我们成功设计并合成了模拟所提出的β-转角结构的杂合肽模拟底物和抑制剂。结果表明,转角构象是凝血酶特异性的一个重要方面,并且我们的转角模拟设计成功模拟了纤维蛋白肽与凝血酶结合的构象。